Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.

Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, Uchi H, Miyazaki S, Abe T, Hagihara A, Moroi Y, Furue M.

J Am Acad Dermatol. 2011 Dec;65(6):1152-60. doi: 10.1016/j.jaad.2010.10.019. Epub 2011 Jun 23.

PMID:
21700362
[PubMed - indexed for MEDLINE]
2.

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.

Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y, Furue M.

J Dermatol Sci. 2011 Oct;64(1):39-44. doi: 10.1016/j.jdermsci.2011.06.007. Epub 2011 Jun 23.

PMID:
21767935
[PubMed - indexed for MEDLINE]
3.

Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.

Weinlich G, Bitterlich W, Mayr V, Fritsch PO, Zelger B.

Br J Dermatol. 2003 Sep;149(3):535-41.

PMID:
14510986
[PubMed - indexed for MEDLINE]
4.

Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.

Oba J, Moroi Y, Nakahara T, Abe T, Hagihara A, Furue M.

Br J Dermatol. 2011 Sep;165(3):506-12. doi: 10.1111/j.1365-2133.2011.10409.x. Epub 2011 Jul 28.

PMID:
21574974
[PubMed - indexed for MEDLINE]
5.

CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression.

Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE.

Mod Pathol. 2004 Oct;17(10):1251-8.

PMID:
15205682
[PubMed - indexed for MEDLINE]
Free Article
6.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
[PubMed - indexed for MEDLINE]
7.

KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.

Janku F, Novotny J, Julis I, Julisova I, Pecen L, Tomancova V, Kocmanova G, Krasna L, Krajsova I, Stork J, Petruzelka L.

Melanoma Res. 2005 Aug;15(4):251-6.

PMID:
16034302
[PubMed - indexed for MEDLINE]
8.

Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.

Owen SA, Sanders LL, Edwards LJ, Seigler HF, Tyler DS, Grichnik JM.

Cancer. 2001 Mar 1;91(5):983-91.

PMID:
11251950
[PubMed - indexed for MEDLINE]
9.

CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.

Thies A, Moll I, Berger J, Wagener C, Brümmer J, Schulze HJ, Brunner G, Schumacher U.

J Clin Oncol. 2002 May 15;20(10):2530-6.

PMID:
12011132
[PubMed - indexed for MEDLINE]
10.

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.

J Clin Oncol. 2007 Mar 1;25(7):869-75.

PMID:
17327608
[PubMed - indexed for MEDLINE]
11.

Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.

Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M.

Cancer. 1999 Mar 1;85(5):1067-76.

PMID:
10091790
[PubMed - indexed for MEDLINE]
12.

Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.

Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS.

Cancer. 2000 Feb 1;88(3):589-95.

PMID:
10649252
[PubMed - indexed for MEDLINE]
13.

Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.

Weinlich G, Topar G, Eisendle K, Fritsch PO, Zelger B.

J Eur Acad Dermatol Venereol. 2007 May;21(5):669-77.

PMID:
17447982
[PubMed - indexed for MEDLINE]
14.

Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.

Svobodová S, Browning J, MacGregor D, Pollara G, Scolyer RA, Murali R, Thompson JF, Deb S, Azad A, Davis ID, Cebon JS.

Eur J Cancer. 2011 Feb;47(3):460-9. doi: 10.1016/j.ejca.2010.09.042. Epub 2010 Nov 4.

PMID:
21115342
[PubMed - indexed for MEDLINE]
15.

Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.

Thörn M, Pontén F, Bergström R, Sparén P, Adami HO.

J Natl Cancer Inst. 1994 May 18;86(10):761-9.

PMID:
8169974
[PubMed - indexed for MEDLINE]
16.

Clinicopathologic analysis of malignant melanoma in Taiwan.

Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC.

J Am Acad Dermatol. 1999 Dec;41(6):945-9.

PMID:
10570378
[PubMed - indexed for MEDLINE]
17.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
[PubMed - indexed for MEDLINE]
18.

Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.

Chen T, Zhu J.

Med Oncol. 2010 Dec;27(4):1185-91. doi: 10.1007/s12032-009-9357-y. Epub 2009 Nov 17.

PMID:
19921476
[PubMed - indexed for MEDLINE]
19.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

PMID:
20108306
[PubMed - indexed for MEDLINE]
Free Article
20.

Prognostic significance of cytoplasmic p27 expression in human melanoma.

Chen G, Cheng Y, Zhang Z, Martinka M, Li G.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2212-21. doi: 10.1158/1055-9965.EPI-11-0472. Epub 2011 Aug 9.

PMID:
21828232
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk